BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9444951)

  • 1. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints.
    Thompson DA; Belinsky G; Chang TH; Jones DL; Schlegel R; Münger K
    Oncogene; 1997 Dec; 15(25):3025-35. PubMed ID: 9444951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
    Duensing S; Münger K
    Cancer Res; 2002 Dec; 62(23):7075-82. PubMed ID: 12460929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
    Chen QM; Merrett JB; Dilley T; Purdom S
    Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes.
    Steinmann KE; Pei XF; Stöppler H; Schlegel R; Schlegel R
    Oncogene; 1994 Feb; 9(2):387-94. PubMed ID: 8290252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
    Liu Y; McKalip A; Herman B
    J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy.
    Liu Y; Heilman SA; Illanes D; Sluder G; Chen JJ
    Cancer Res; 2007 Mar; 67(6):2603-10. PubMed ID: 17363579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
    Liu X; Han S; Baluda MA; Park NH
    Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells.
    Chang TH; Ray FA; Thompson DA; Schlegel R
    Oncogene; 1997 May; 14(20):2383-93. PubMed ID: 9188853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
    Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
    Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
    Lathion S; Schaper J; Beard P; Raj K
    Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.
    Thomas JT; Laimins LA
    J Virol; 1998 Feb; 72(2):1131-7. PubMed ID: 9445009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
    Toussaint-Smith E; Donner DB; Roman A
    Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.
    Stöppler H; Stöppler MC; Johnson E; Simbulan-Rosenthal CM; Smulson ME; Iyer S; Rosenthal DS; Schlegel R
    Oncogene; 1998 Sep; 17(10):1207-14. PubMed ID: 9771963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways.
    Shin KH; Ahn JH; Kang MK; Lim PK; Yip FK; Baluda MA; Park NH
    Int J Oncol; 2006 Jan; 28(1):209-15. PubMed ID: 16327998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.